Scientists test 'Glowing' tracer to see inside tumors
NCT ID NCT05259709
Summary
This study is testing a new imaging agent, 89Zr-DFO-REGN5054, to see if it can safely create pictures of certain immune cells inside tumors. It involves up to 50 adults with advanced solid cancers who are also receiving the immunotherapy drug cemiplimab. The main goal is to check the safety of the imaging agent and see if the pictures it creates can help doctors understand how the immune system is fighting the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UMC Groningen
RECRUITINGGroningen, 9700 RB, Netherlands
Conditions
Explore the condition pages connected to this study.